KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Current Assets (2016 - 2025)

Historic Current Assets for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $395.2 million.

  • Chemed's Current Assets fell 1941.0% to $395.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $395.2 million, marking a year-over-year decrease of 1941.0%. This contributed to the annual value of $394.7 million for FY2024, which is 2118.33% down from last year.
  • As of Q3 2025, Chemed's Current Assets stood at $395.2 million, which was down 1941.0% from $491.4 million recorded in Q2 2025.
  • Chemed's Current Assets' 5-year high stood at $539.6 million during Q1 2024, with a 5-year trough of $184.8 million in Q1 2022.
  • Its 5-year average for Current Assets is $351.6 million, with a median of $347.0 million in 2021.
  • As far as peak fluctuations go, Chemed's Current Assets crashed by 4675.36% in 2022, and later skyrocketed by 10578.71% in 2024.
  • Over the past 5 years, Chemed's Current Assets (Quarter) stood at $230.3 million in 2021, then rose by 18.38% to $272.6 million in 2022, then skyrocketed by 83.72% to $500.8 million in 2023, then decreased by 21.18% to $394.7 million in 2024, then increased by 0.13% to $395.2 million in 2025.
  • Its Current Assets was $395.2 million in Q3 2025, compared to $491.4 million in Q2 2025 and $502.4 million in Q1 2025.